Rehearing Denied in Federal Circuit’s Ruling Against Tecfidera® Patent for Lack of Written Description

Print PDF Icon
Authored by Xiaoban Xin and published in Wolters Kluwer IP Litigator

Associate Xiaoban Xin's article, "Rehearing Denied in Federal Circuit’s Ruling Against Tecfidera® Patent for Lack of Written Description," originally published on the firm's biosimilars blog, Biosimilars Law Bulletin, was published in Wolters Kluwer's IP Litigator, July/August 2022, Volume 28 Number 4.

IP Litigator provides briefings on the latest thinking and strategies for successful intellectual property litigation and enforcement. Each issue supplies valuable guidance and practice tips from top litigators and industry experts in patent, copyright, ITC and customs, trademark, and international litigation. From policing the market for infringers, to conducting discovery, selecting expert witnesses, or calculating damages, you'll discover the proven methods winning today's IP cases.

To read the article, please click on the PDF linked below.

Related Materials

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.